PlainRecalls
FDA Drug Critical Class I Terminated

1% LIDOCAINE HCl Injection, USP, 10 mg/mL, 30 mL Single-dose, Preservative-Free glass vial (Twenty-five (25) units per box/fifty (50) units per case, NDC 0409-4279-02, Hospira, Inc., Lake Forest, IL 60045

Reported: February 25, 2015 Initiated: October 16, 2014 #D-0391-2015

Product Description

1% LIDOCAINE HCl Injection, USP, 10 mg/mL, 30 mL Single-dose, Preservative-Free glass vial (Twenty-five (25) units per box/fifty (50) units per case, NDC 0409-4279-02, Hospira, Inc., Lake Forest, IL 60045

Reason for Recall

Presence of particulate matter: A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper.

Details

Recalling Firm
Hospira Inc.
Units Affected
100,100 units
Distribution
Nationwide
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
1% LIDOCAINE HCl Injection, USP, 10 mg/mL, 30 mL Single-dose, Preservative-Free glass vial (Twenty-five (25) units per box/fifty (50) units per case, NDC 0409-4279-02, Hospira, Inc., Lake Forest, IL 60045. Recalled by Hospira Inc.. Units affected: 100,100 units.
Why was this product recalled?
Presence of particulate matter: A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 25, 2015. Severity: Critical. Recall number: D-0391-2015.